These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34188542)

  • 1. CA19-9 Level to Serum γ-Glutamyltransferase as a Potential Prognostic Biomarker in Patients with Pancreatic Head Carcinoma.
    Lyu SC; Wang J; Huang M; Wang HX; Zhou L; He Q; Lang R
    Cancer Manag Res; 2021; 13():4887-4898. PubMed ID: 34188542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ratio of CA19-9 level to total bilirubin as a novel prognostic indicator in patients with pancreatic head carcinoma following curative resection.
    Xu WL; Wang J; Lyu SC; Zhou L; He Q; Lang R
    Gland Surg; 2021 Mar; 10(3):980-991. PubMed ID: 33842242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbohydrate antigen 19-9 as a novel prognostic biomarker in distal cholangiocarcinoma.
    Jiang T; Lyu SC; Zhou L; Wang J; Li H; He Q; Lang R
    World J Gastrointest Surg; 2021 Sep; 13(9):1025-1038. PubMed ID: 34621478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative CA19-9 and GGT ratio as a prognostic indicator in ampullary carcinoma.
    Chen RQ; Zhang ZL; Jia YM; Chen RX; Peng L
    BMC Gastroenterol; 2023 Mar; 23(1):72. PubMed ID: 36915042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery.
    Li S; Xu H; Wu C; Wang W; Jin W; Gao H; Li H; Zhang S; Xu J; Zhang W; Xu S; Li T; Ni Q; Yu X; Liu L
    Cancer Med; 2019 Feb; 8(2):572-584. PubMed ID: 30632317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ratio of CA19-9 Level to Total Tumor Volume as a Prognostic Predictor of Pancreatic Carcinoma After Curative Resection.
    Xu J; Lyu S; Zhao Y; Zhang X; Liu Z; Zhao X; He Q
    Technol Cancer Res Treat; 2022; 21():15330338221078438. PubMed ID: 35138217
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevation of serum γ-glutamyltransferase as a predictor of aggressive tumor behaviors and unfavorable prognosis in patients with intrahepatic cholangiocarcinoma: analysis of a large monocenter study.
    Yin X; Zheng SS; Zhang BH; Zhou Y; Chen XH; Ren ZG; Qiu SJ; Fan J
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1408-14. PubMed ID: 23839159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of the ratio of preoperative CA19-9 to liver enzyme levels in pancreatic cancer patients with jaundice (predictability of combined CA19-9/AST and CA19-9/γ-GGT for jaundiced PDAC patients).
    Huang X; Lu Z; Zhang K; Wang G; Cai B; Wu P; Yin J; Miao Y; Jiang K
    Pancreatology; 2021 May; ():. PubMed ID: 34090807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy.
    Shin K; Jung EK; Park SJ; Jeong S; Kim IH; Lee MA
    World J Gastrointest Oncol; 2021 Aug; 13(8):915-928. PubMed ID: 34457195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma.
    Wen YF; Yang XZ; Zeng LS; Peng HH; Huang WJ; Cai LM; Zhou TC; Lin XD
    PLoS One; 2017; 12(2):e0172345. PubMed ID: 28241022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrate antigen 19-9 as a prognostic biomarker in pancreatic neuroendocrine tumors.
    Luo G; Jin K; Cheng H; Liu C; Guo M; Lu Y; Yang C; Xu J; Wang W; Gao H; Zhang S; Long J; Xu J; Ni Q; Chen J; Yu X
    Oncol Lett; 2017 Dec; 14(6):6795-6800. PubMed ID: 29163700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer.
    He WZ; Guo GF; Yin CX; Jiang C; Wang F; Qiu HJ; Chen XX; Rong RM; Zhang B; Xia LP
    Colorectal Dis; 2013 Aug; 15(8):e443-52. PubMed ID: 23621885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of gamma-glutamyltransferase in patients with resectable esophageal squamous cell carcinoma.
    Yang F; Zhang S; Yang H; Luo K; Wen J; Hu Y; Hu R; Huang Q; Chen J; Fu J
    Dis Esophagus; 2015 Jul; 28(5):496-504. PubMed ID: 24766310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
    Wang JK; Hu HJ; Shrestha A; Ma WJ; Yang Q; Liu F; Cheng NS; Li FY
    Oncotarget; 2017 Jul; 8(28):45335-45344. PubMed ID: 28484084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer.
    Asaoka T; Miyamoto A; Maeda S; Tsujie M; Hama N; Yamamoto K; Miyake M; Haraguchi N; Nishikawa K; Hirao M; Ikeda M; Sekimoto M; Nakamori S
    Pancreatology; 2016; 16(3):434-40. PubMed ID: 26852169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients.
    Aoki S; Motoi F; Murakami Y; Sho M; Satoi S; Honda G; Uemura K; Okada KI; Matsumoto I; Nagai M; Yanagimoto H; Kurata M; Fukumoto T; Mizuma M; Yamaue H; Unno M;
    BMC Cancer; 2019 Mar; 19(1):252. PubMed ID: 30898101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study.
    Dong Q; Yang XH; Zhang Y; Jing W; Zheng LQ; Liu YP; Qu XJ
    World J Surg Oncol; 2014 Jun; 12():171. PubMed ID: 24890327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative serum CA125 levels predict the prognosis in hyperbilirubinemia patients with resectable pancreatic ductal adenocarcinoma.
    Chen T; Zhang MG; Xu HX; Wang WQ; Liu L; Yu XJ
    Medicine (Baltimore); 2015 May; 94(19):e751. PubMed ID: 25984661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of SUVmax and serum carbohydrate antigen 19-9 in pancreatic cancer.
    Zhao JG; Hu Y; Liao Q; Niu ZY; Zhao YP
    World J Gastroenterol; 2014 May; 20(19):5875-80. PubMed ID: 24914348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Albumin-Bilirubin Grade as a Useful Prognostic Indicator in Patients With Pancreatic Cancer.
    Yagyu T; Saito H; Sakamoto T; Uchinaka EI; Morimoto M; Amisaki M; Watanabe J; Tokuyasu N; Honjo S; Ashida K; Fujiwara Y
    Anticancer Res; 2019 Mar; 39(3):1441-1446. PubMed ID: 30842180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.